Article
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.
Movement disorders : official journal of the Movement Disorder Society - 1 Jan 2007
Ishihara Lianna, Gibson Rachel A, Warren Liling, Amouri Rim, Lyons Kelly, Wielinski Catherine, Hunter Christine, Swartz Jina E, Elango Ramu, Akkari P Anthony, Leppert David, Surh Linda, Reeves Kevin H, Thomas Siwan, Ragone Leigh, Hattori Nobutaka, Pahwa Rajesh, Jankovic Joseph, Nance Martha, Freeman Alan, Gouider-Khouja Neziha, Kefi Mounir, Zouari Mourad, Ben Sassi Samia, Ben Yahmed Samia, El Euch-Fayeche Ghada, Middleton Lefkos, Burn David J, Watts Ray L, Hentati Faycal
Abstract excerpt
Mutations in the leucine-rich repeat kinase-2 gene (LRRK2) are responsible for some forms of familial as well as sporadic Parkinson's disease (PD). The purpose of this study was to examine the frequency of a single pathogenic mutation (6055G > A) in the kinase domain of this gene in United States and Tunisian familial PD and to compare clinical characteristics between patients with and without the mutation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.